Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

NCT00308711 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1308

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Ripening
Labor, Induced

Interventions

DRUG: Misoprostol vaginal insert 100 mcg
DRUG: Misoprostol vaginal insert 50 mcg
DRUG: Dinoprostone vaginal insert (Cervidil)

Sponsor

Ferring Pharmaceuticals